Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T17:31:48.633Z.
Calculation as of: 2026-10-06T17:31:48.633Z.
Quote observation: 2026-10-06T17:30:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1f516b86ce6f8a32b007838909cf85d374f635633f340bc308fa792387434ce1
EARNINGS YIELD
N/A
Market Cap
$268.62M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$269.77M
Earnings Yield
N/A
TTM Avg
17.92%
3Y Avg
17.92%
5Y Avg
17.92%
Market Cap
$270.52M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$266.00M
Earnings Yield
N/A
TTM Avg
0.57%
3Y Avg
0.57%
5Y Avg
0.57%
Market Cap
$264.16M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.03M
Earnings Yield
N/A
TTM Avg
7.35%
3Y Avg
8.08%
5Y Avg
6.30%
Market Cap
$262.09M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fate Therapeutics, Inc. (FATE) | $268.67M | N/A | N/A | N/A | N/A |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $268.62M | N/A | N/A | N/A | N/A |
| Scribe Therapeutics Inc. (SCTX)vs › | $267.73M | N/A | N/A | N/A | N/A |
| SAB Biotherapeutics, Inc. (SABS)vs › | $269.77M | N/A | 17.92% | 17.92% | 17.92% |
| Treace Medical Concepts, Inc. (TMCI)vs › | $270.52M | N/A | N/A | N/A | N/A |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $266.00M | N/A | 0.57% | 0.57% | 0.57% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $264.16M | N/A | N/A | N/A | N/A |
| OraSure Technologies, Inc. (OSUR)vs › | $264.03M | N/A | 7.35% | 8.08% | 6.30% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $262.09M | N/A | N/A | N/A | N/A |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $262.00M | N/A | 6.60% | 6.60% | 6.49% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
